Financials DIGL HEAL

Equities

DHAC

US2538931013

Market Closed - Nasdaq 16:30:01 2024-06-28 EDT 5-day change 1st Jan Change
8.75 USD -2.78% Intraday chart for DIGL HEAL -27.75% -28.28%

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 128.5 45.3 43.97
Enterprise Value (EV) 1 127.8 46.42 48.16
P/E ratio - -42.8 x -11.3 x
Yield - - -
Capitalization / Revenue - - -
EV / Revenue - - -
EV / EBITDA - - -
EV / FCF - 709,878,401 x -38,073,230 x
FCF Yield - 0% -0%
Price to Book -44.2 x -6.1 x -3.58 x
Nbr of stocks (in thousands) 13,009 4,156 3,604
Reference price 2 9.880 10.90 12.20
Announcement Date 22-03-29 23-04-12 24-04-12
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -0.3769 -3.595 -2.594
Operating Margin - - -
Earnings before Tax (EBT) 1 -0.3743 -3.055 -4.414
Net income 1 -0.3743 -3.243 -4.414
Net margin - - -
EPS - -0.2545 -1.078
Free Cash Flow - 0.0654 -1.265
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 22-03-29 23-04-12 24-04-12
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 - 1.12 4.19
Net Cash position 1 0.72 - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow - 0.07 -1.26
ROE (net income / shareholders' equity) - 60.3% 44.8%
ROA (Net income/ Total Assets) - -3.58% -36%
Assets 1 - 90.62 12.26
Book Value Per Share 2 -0.2200 -1.790 -3.400
Cash Flow per Share 2 0.0500 0.0300 0
Capex - - -
Capex / Sales - - -
Announcement Date 22-03-29 23-04-12 24-04-12
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA